← Back to headlines
Immunocore Details TEBE-AM Data Timeline and KIMMTRAK Expansion
Immunocore has provided an update on its drug development, indicating that TEBE-AM data could be available as early as the end of 2026, while also planning to scale KIMMTRAK to treat over 1,000 patients annually.
6 Aug, 22:45 — 6 Aug, 22:45
Sources
Showing 1 of 1 sources
